DK400884A - Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden - Google Patents

Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden Download PDF

Info

Publication number
DK400884A
DK400884A DK400884A DK400884A DK400884A DK 400884 A DK400884 A DK 400884A DK 400884 A DK400884 A DK 400884A DK 400884 A DK400884 A DK 400884A DK 400884 A DK400884 A DK 400884A
Authority
DK
Denmark
Prior art keywords
octahydropyrazolo
quinolines
tautomer
alkylated
intermediates
Prior art date
Application number
DK400884A
Other languages
Danish (da)
English (en)
Other versions
DK400884D0 (da
Inventor
John Mehnert Schaus
Diane Lynn Huser
Richard Nolan Booher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK400884D0 publication Critical patent/DK400884D0/da
Publication of DK400884A publication Critical patent/DK400884A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK400884A 1983-09-26 1984-08-22 Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden DK400884A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53551983A 1983-09-26 1983-09-26

Publications (2)

Publication Number Publication Date
DK400884D0 DK400884D0 (da) 1984-08-22
DK400884A true DK400884A (da) 1985-03-27

Family

ID=24134591

Family Applications (1)

Application Number Title Priority Date Filing Date
DK400884A DK400884A (da) 1983-09-26 1984-08-22 Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden

Country Status (10)

Country Link
EP (1) EP0145121B1 (forum.php)
JP (4) JPS6110583A (forum.php)
KR (1) KR870001159B1 (forum.php)
CA (1) CA1270488A (forum.php)
DE (1) DE3484925D1 (forum.php)
DK (1) DK400884A (forum.php)
GB (1) GB2146984B (forum.php)
GR (1) GR80200B (forum.php)
HU (1) HU199836B (forum.php)
IL (1) IL72729A (forum.php)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6392722A (ja) * 1986-10-03 1988-04-23 Unitika Ltd 熱接着繊維およびその不織布
JPS6392723A (ja) * 1986-10-06 1988-04-23 Unitika Ltd 湿潤性複合繊維およびその不織布
JPS6420322A (en) * 1987-07-13 1989-01-24 Mitsubishi Petrochemical Co Conjugated fiber
JPH01204617A (ja) * 1988-02-09 1989-08-17 Chisso Corp 敷物
GB8828669D0 (en) * 1988-12-08 1989-01-11 Lilly Industries Ltd Organic compounds
KR20000008130A (ko) * 1998-07-10 2000-02-07 조정래 폴리에스터계 탄성사용 공중합물의 제조방법
WO2012094618A1 (en) 2011-01-07 2012-07-12 Corcept Therapeutics, Inc. Combination steroid and glucocorticoid receptor antagonist therapy
WO2013130420A1 (en) * 2012-02-27 2013-09-06 Corcept Therapeutics, Inc. Phenyl heterocycloalkyl glucocorticoid receptor modulators
US12226412B2 (en) 2012-05-25 2025-02-18 Corcept Therapeutics, Inc. Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
US8859774B2 (en) 2012-05-25 2014-10-14 Corcept Therapeutics, Inc. Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
WO2015077530A1 (en) 2013-11-25 2015-05-28 Corcept Therapeutics, Inc. Octahydro fused azadecalin glucocorticoid receptor modulators
CA3055076C (en) 2017-03-31 2022-02-22 Corcept Therapeutics, Inc. Glucocorticoid receptor modulators to treat cervical cancer
WO2020132046A1 (en) 2018-12-19 2020-06-25 Corcept Therapeutics Incorporated Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
US11234971B2 (en) 2018-12-19 2022-02-01 Corcept Therapeutics Incorporated Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
AU2019404026B2 (en) 2018-12-19 2023-06-08 Corcept Therapeutics Incorporated Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
EP3927345A4 (en) 2019-02-22 2022-12-21 Corcept Therapeutics Incorporated Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
MX2022006633A (es) 2019-12-11 2022-06-24 Corcept Therapeutics Inc Metodos de tratamiento del aumento de peso inducido por antipsicoticos con miricorilant.
WO2022134033A1 (en) 2020-12-25 2022-06-30 Corcept Therapeutics Incorporated Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198415A (en) * 1979-01-22 1980-04-15 Eli Lilly And Company Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
US4230861A (en) * 1979-01-22 1980-10-28 Eli Lilly And Company 1-And/or 7-substituted-6-hydroxy (or oxo)-3-decahydroquinoline carboxylic acids
SU776048A1 (ru) * 1979-06-05 1983-09-23 Институт Бисорганической Химии Ан Бсср Производные 8-аза-16-оксагона-17-онов, про вл ющие противовоспалительную,мембраностабилизирующую и антифибринолитическую активность,и способ их получени
US4252945A (en) * 1979-07-11 1981-02-24 E. R. Squibb & Sons, Inc. Process for preparing pyrazolo[1,5-c]-quinazoline derivatives and novel intermediates
US4367231A (en) * 1979-09-14 1983-01-04 Eli Lilly And Company Method of using octahydro pyrazolo[3,4-g]quinolines
ES8504174A1 (es) * 1982-11-03 1985-04-16 Lilly Co Eli Un procedimiento para la preparacion de derivados de pirazolo-quinolinas.

Also Published As

Publication number Publication date
JPH05194527A (ja) 1993-08-03
GR80200B (en) 1985-01-02
GB2146984B (en) 1987-04-08
JPH0660183B2 (ja) 1994-08-10
GB2146984A (en) 1985-05-01
HUT34750A (en) 1985-04-28
EP0145121B1 (en) 1991-08-14
JPS6110583A (ja) 1986-01-18
HU199836B (en) 1990-03-28
IL72729A0 (en) 1984-11-30
JPH05194511A (ja) 1993-08-03
DK400884D0 (da) 1984-08-22
JPH0568475B2 (forum.php) 1993-09-29
EP0145121A2 (en) 1985-06-19
KR870001159B1 (ko) 1987-06-13
DE3484925D1 (de) 1991-09-19
EP0145121A3 (en) 1988-04-27
JPH0625251A (ja) 1994-02-01
GB8421159D0 (en) 1984-09-26
KR850002480A (ko) 1985-05-13
CA1270488A (en) 1990-06-19
IL72729A (en) 1988-02-29

Similar Documents

Publication Publication Date Title
DK400884A (da) Tautomere trans-(+-)-alkylerede octahydropyrazolo(3,4-g)- og -(4,3-f)-quinoliner, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden
NO854826L (no) Fremgangsmaate og apparat for broennboring.
DK381485D0 (da) 1,2-benzisothiazol-3-yl-piperazinderivater og fremgangsmaade til fremstilling deraf
DK175882A (da) Magnetiske ruller og fremgangsmaade til fremstilling deraf
DK445884D0 (da) Fremgangsmaade til fremstilling af 1,4-dialkyl-3-methyl-4-(3-substitueret phenyl)-piperidiner og mellemprodukt til brug ved fremgangsmaaden
DK321382A (da) Lineaere basiske polymerisater og fremgangsmaade til fremstilling heraf
DK385884A (da) 2,6-substituerede 3,5-pyridin-dicarboxylsyre-derivater og fremgangsmaade til fremstilling heraf
DE3262019D1 (en) Soft-cover book block and method for the manufacture of same
DK172485A (da) 23,23-difluor-1,25-dihydroxycholecalciferol og derivater deraf, fremgangsmaade til fremstilling af disse og mellemprodukter til brug herved
FR2554444B1 (fr) 1,25-dihydroxyvitamines d2 et procedes pour les preparer
DK32684D0 (da) Fremgangsmade til fremstilling af 26,26,26,27,27,27-hexafluorlalfa,25-dihydroxycholesterol og mellemprodukter til brug herfor
DK195585D0 (da) 4'-deschlorrebeccamycin og fremgangsmaade til fremstilling af samme
DK511884D0 (da) Leukotrienantagonister og fremgangsmaade til fremstilling deraf
NO864411L (no) Fremgangsmaate og innretning for kontinuerlig strenggrafittering av karbon-formlegemer.
DK165952C (da) 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf
NO812493L (no) Metode for aa aapne, sammenfolde og rotere stive baatseil
PL232330A1 (en) Method of obtaining new derivatives of oxazolidinodione-2,4
DK416888A (da) Cephalosporinforbindelser, krystallinske derivater deraf, mellemprodukter til brug ved fremstilling af cephalosporinforbindelser og fremgangsmaader til fremstilling af cephalosporinforbindelser
PL253821A1 (en) Method of obtaining derivatives of 1,4-dihydropyridine
PL253820A1 (en) Method of obtaining derivatives of 1,4-dihydropyridine
DK406484A (da) 16-flour-16,17-didehydroprostanoider samt fremgangsmaade til og mellemprodukter ved fremstilling heraf
IS2902A7 (is) Aðferð til framleiðslu á 1,8-dihydroxy-10-acyl-9-anthrones, sérstaklega til meðferðar á psoriasis
DK52885D0 (da) 1,3,2-dioxaborinan-forbindelser og fremgangsmaade til fremstilling heraf
DK449388D0 (da) Disubstituerede tetrazol-forbindelser med leukotrien-antagonistvirkning, fremgangsmaade til fremstilling heraf og mellemprodukt til brug ved fremgangsmaaden
NO159764C (no) Fremgangsmaate og anordning ved fremstilling av pariserpoteter.

Legal Events

Date Code Title Description
ATS Application withdrawn